EVENTS

We’re delighted to announce that Dr. Wahid Awad, CEO, will be present at the 7th edition of “Phases Précoces en Cancérologie”, taking place on Thursday, November 20, 2025, at the Palais des Congrès d’Issy-les-Moulineaux. This leading academic event brings together key experts and stakeholders in oncology to discuss the latest innovations and collaborations in early-phase cancer research. Come meet us, exchange insights, and explore new opportunities to advance cancer treatment together.

Our CEO Dr. Wahid Awad, Ph.D. MBA had the chance to connect with the tri-national ecosystem bridging Switzerland, France, and Germany. This is a unique platform where startups, corporates, and investors come together to accelerate healthtech innovation. At Rosetta Omics, we’re eager to explore collaboration opportunities in oncology and precision medicine, and to discuss how AI and multi-omics can transform patient care with investors, hospitals; biotech, pharma, academics and governments.

📰 BIO-Europe 2025, Vienna 📰
Rosetta Omics is looking forward to meeting you all in Vienna, Austria from November 3–5 at BIO-Europe 2025 organized by EBD Group Informa
Rosetta Omics is proud to be part of the French delegation and connect with the European and global healthtech and biotech ecosystem.

Dr. Wahid Awad, Ph.D. MBA Rosetta Omics CEO attended the 11th SFMPP – Société Française de Médecine Prédictive et Personnalisée Congress
Dates: October 8–10, 2025
Place: Coeur Défense in Paris
This year’s theme:
AI and Genomics: the twin drivers of medical innovation and personalization.
The congress will explore how these technologies are reshaping healthcare, from screening to treatment.
Rosetta Omics is one of the players in this field leveraging multiomics data and AI to unlock the road to precision medicine in oncology.
Congress key topics will include:
– Advances in omics for cancer and rare diseases
– The impact and ethics of AI in medicine
– New practices and recommendations for NGS testing
– Insights into rising cancer rates among young people
– Pharmacogenomics, forensics, and cutting-edge innovation in precision medicine
A big thank you to Prof. Pascal Pujol, Dr. David Genevieve, and Dr. Stéphane Loze and the entire Scientific Committee for organizing such an impactful event.

We attended BIG 2025 (Bpifrance Inno Generation), the largest deeptech conference organized by Bpifrance After participating in the last three years editions (2022,2023, and 2024).
This was an opportunity to connect with the Bpifrance team, the European Commission and other investors to discuss funding opportunities, meet with like minded entrepreneurs from France, Europe and all over the world to exchange ideas and forge partnerships.
BIG is always a unique moment to share, learn, and grow.

📰 AI4Immuno-Oncology 📰
Our CEO, Dr. Wahid Awad, Ph.D. MBA, participated in the AI4Immuno-Oncology: Advancing Cancer Care Through AI.
This summit was co-organized by Future4care and Paris Saclay Cancer Cluster (PSCC).
This event bring together leading voices to explore how AI is transforming cancer research, therapy design, and personalized treatment.

Rosetta Omics had the privilege to participate in the BIO International Convention in Boston, one of the world’s most dynamic biotech and pharma hubs. Under the theme “The World Cannot Wait,” the convention brought together global leaders committed to accelerating innovation in life sciences and delivering solutions to patients faster. The week began with the Boston-Paris Biotech Summit, a unique forum celebrating transatlantic collaboration and setting the tone for a rich and productive agenda. Our CEO, Dr. Wahid Awad, Ph.D. MBA , engaged in numerous inspiring and strategic conversations with key players across biotech, pharma, and health tech from North America, Asia, Europe and the middle east. These discussions reaffirmed the growing global momentum for AI-driven multiomics and precision oncology. The week also featured several exciting side events, including: “Founding the Future: Europe’s Life Sciences Hub” at Hôtel-Dieu, in partnership with BioLabs BioLabs France Hotel Dieu Hospital, highlighting Paris’s innovation leadership in Europe. This event included a visit to LabCentral in Cambridge, a world-class space nurturing the next generation of biotech breakthroughs. A special moment for Rosetta Omics: a visit to our future U.S. subsidiary office at the Cambridge Innovation Center (CIC (Cambridge Innovation Center) in Kendall Square. More to come on this soon! We were also honored to welcome the French Ambassador to the United States at the French Pavilion, where Rosetta Omics and many other French innovators showcased the strength and ambition of France’s biotech ecosystem on the global stage. A sincere thank you to Business France Business France North America Business France Healthcare – North America and to all our partners at the French Pavilion (Choose Paris Region ICOSA France Biotech) and many others) for their exceptional support and commitment to promoting French innovation worldwide. Boston continues to inspire with its scientific excellence, entrepreneurial spirit, and openness to global collaboration.

At GITEX AFRICA 2025, StartGate reaffirmed one of its core strategic objectives: building high-impact partnerships with public and private stakeholders to co-create sector-specific programs. Some of our flagship programs took center stage, demonstrating the power of tailored support in transforming bold ideas into impactful ventures. From early-stage acceleration to scale-up support, these programs empowered visionary entrepreneurs to showcase their startups globally. Beyond the exhibition space, our teams and their partners co-hosted insightful panels, deep diving into how collaborative, purpose-driven programs can address Africa’s most pressing challenges, including climate resilience, smart retail, sustainable agriculture, health tech, and beyond.

With concluding remarks from his excellency the, ambassador of the Netherlands in France and the president of MEDEF Mr. Patrick Martin, Today, May 27, 2025, We had the honor of participating in the Franco-Dutch Conference on Innovation and Economic Cooperation, held at MEDEF headquarters in Paris. This event marked the two-year anniversary of the Franco-Dutch Pact for Innovation and Sustainable Growth, a significant milestone in the collaborative efforts between France and the Netherlands to drive innovation, sustainability, and industrial resilience. The conference provided a platform to explore strategic synergies between France 2030 and the Dutch National Technology Strategy, focusing on Strategic synergies between national innovation strategies, Funding mechanisms for joint innovation initiatives, and talent development to support green and digital transitions. The event featured high-level speakers from both governments, industry leaders, and representatives from organisations such as the European Investment Bank (EIB) (Nathalie Climence and Netherlands Foreign Investment Agency (Jellie Banga) and Bpifrance (Christian Dubarry). It was inspiring to witness the commitment to fostering a collaborative environment that drives sustainable economic growth and technological advancement

The event was a remarkable experience, made even more special by being invited to the exclusive investors tour, where I had the opportunity to network one-on-one with VCs actively investing in AI and healthcare innovation. The summit, organized by Artifact and co-founded by Johnson & Johnson Innovative Medicine, brought together 2,000 participants—a true testament to the growing momentum in the field of AI & Health. Beyond the inspiring discussions, I was delighted to reconnect with old friends and forge new connections that will undoubtedly shape the future of healthcare. At Rosetta Omics, we’re at the forefront of transforming oncology through AI-powered precision medicine. By integrating advanced spatial and multiomics data, we’re uncovering novel biomarkers and validating therapeutic targets, enabling more effective and personalized cancer treatments. Our mission is to empower physicians with tools to deliver the right treatment to the right patient at the right time. Events like this remind me how innovation, collaboration, and shared vision can truly revolutionize healthcare. I look forward to being back next year and contributing even further to the science and innovation in this transformative era of healthcare and AI.

Rosetta Omics in Africa! What an incredible experience at GITEX AFRICA in the beautiful Morocco! A big thank you to UM6P – University Mohammed VI Polytechnic UM6P France, UM6P Ventures for the kind invitation and warm welcome. The energy across panels, meetings, and the buzzing African and international startup + AI ecosystem was truly inspiring. Proud to have been selected as part of the Next Africa program, and grateful for the opportunity to connect with so many brilliant minds and visionary partners in Marrakech and Ben Guerir. It’s time to build bridges between Africa and Europe.

Dr. Wahid Awad, Ph.D. MBA, our CEO present this year at Viva Technology in Paris from 11-14 June 2025. Rosetta Omics is a deeptech (as qualified by Bpifrance and Hello Tomorrow) healthcare startup based in Paris, and incubated at the prestigious Agoranov incubator and STATION F. Rosetta is at the forefront of precision medicine in oncology, leveraging AI and multiomics data to match cancer patients with the most effective treatments and to discover new biomarkers and therapeutic targets.

To tackle complex issues, we need to have the ambition to build, finance and scale complex solutions. The Hello Tomorrow Global Summit is where it’s all happening. The only event in the world, bringing together corporates, investors, startups, researchers, and institutions during two days (9-10 March 2023) in Paris.

MedInTechs is a major annual exhibition focused on innovation in health, held at the Parc Floral de Paris. The 2023 edition marked its second year, taking place on March 13–14 under the high patronage of President Emmanuel Macron.

Our CSO, Dr. Kevin Adam, PhD, MBE introduced our work on Colorectal Cancer at the 3rd AI for Oncology congress in Milan, Italy led by Arsela Prelaj at the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano. Great discussions and interactions with the community in the field! it is always great to meet with familiar faces and establish connection with this vibrant italian network bringing international experts together from the scientific, medical and industry domains, all aiming for better AI solutions in the field of oncology. We would like to thank our partners from the ICM – Institut du Cancer de Montpellier and Maastricht University for collaborating with us on this work. It was exciting sharing what we are doing at Rosetta Omics and exploring what could be done in the future. We are looking forward to follow up with the recently created ESAC – European Interdisciplinary Society of AI for Cancer Research and to establish strategic collaboration.

Attended Abu Dhabi Global Health Week (ADGHW) 2025 from 15 – 17 April at ADNEC Centre Abu Dhabi, hosted by Department of Heath Abu Dhabi – join me in paving the way ‘towards longevity, redefining health and well-being’.

From thought-provoking discussions on the ever-evolving deal dynamics within the industry to unique insights on the regulatory landscape, women’s health R&D, treatment breakthroughs, and the strategic deployment of AI, some of the greatest minds in pharma and healthcare will convene to explore the most pressing issues and exciting opportunities on the horizon.

We are pleased to announce that the 11th Annual HealthTech Investment Forum (#Sachs_HTIF) will take place on the 24th of September 2024 at the Mövenpick Hotel Basel. The event will be part of the Sachs Autumn Life Sciences Week (#SALSW), which will also incorporate the 24th Annual Biotech in Europe Forum. The physical programme will consist of the usual panels and keynotes, which will be available on-demand from the 2nd of October. Additionally, there will be pre-arranged in-person meetings, live and on-demand company showcases and a reception. During the online week, virtual meetings will be available through the online meeting system. The main programme for the 11th Annual HTIF will feature more than 7 hours of high-level speeches and panel discussions. In addition, there will be a global company showcase of around 20 presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. We anticipate 250+ delegates from Digital Health, MedTech/Device companies, banks, investors and advisors with part of the audience participating virtually.

MedInTechs x Medicen Paris Region: A lasting partnership for the benefit of our members!

✨ MedInTechs has quickly become an unmissable event for discussing the future of innovation and highlighting the solutions of tomorrow. I am delighted to participate in the programming of these days by bringing Medicen’s expertise around major subjects such as Artificial Intelligence or surgical and interventional innovation. With concrete actions to support these values, which Medicen also carries out on a daily basis:

➡️ Promoting health innovation in accordance with Evidence Based Medicine (VBHC)

➡️ Supporting startups and the innovative ecosystem

➡️ Creating sustainable partnerships and federating the sector’s players

We had the privilege of attending the 11th edition of JNDA – BRIDGE AFRICA (Journées Nationales des Diasporas et de l’Afrique) – BRIDGE AFRICA (National Days of the Diaspora and Africa) in Paris. This inspiring event, dedicated to building essential connections within the African ecosystem, goes beyond a simple gathering; it embodies a shared vision of Africa’s future by bringing together talent, fostering valuable exchanges, and encouraging strategic partnerships across the continent. As an African, I was proud to represent Egypt, my home country, and ESCP Business School where I serve as a board member of the alumni association (ESCP Alumni). Alongside partners like the African Business Club, ESCP supported this year’s JNDA with an engaging exhibition stand and a workshop titled “Career Opportunities in Africa,” sparking conversations on the professional prospects, challenges, and growth potential for talent eager to contribute to Africa’s development. Spending my staturday in the company of fellow African leaders was an enriching experience. We explored collaboration opportunities and I envisioned the day my company, Rosetta Omics, would expand its impact into Africa and serving african patients and healthcare institutions.

Our CEO Dr. Wahid Awad, Ph.D. MBA pitching Rosetta Omics during the Boost event organized by the French chamber of commerce CCI Paris IdF at the famous and prestigious world’s most famous tennis stadium Roland-Garros in Paris. https://lnkd.in/e_XuC_3N Rosetta Omics was selected to be among the 16 finalists that were invited to come and pitch on Thursday, November 7 in front of a panel of Business Angels in partnership with France Invest , France Angels and Paris Région Angels. Is it is written in the invitation to pitch: “You have managed to stand out from more than 250 applications submitted, congratulations!!”: “Very much looking forward to presenting Rosetta Omics and to discuss and connect with investors”. Said Dr. Wahid Awad, Ph.D. MBA Thank you Assia CHOUAI , Dominique Restino CCI Paris IdF CCI Entreprises And event partners: AXA , TotalEnergies, Zoho, France Mentor – Institut français du mentorat , Crédit Agricole d’Ile-de-France.

CEO and Co-founder, Dr. Wahid Awad participated in the meet2win conference organized by Matwin in Bordeaux, France. MEET2WIN is an annual partnering convention dedicated to open innovation in oncology. Dr. Awad had more than 20 B2B meetings where he discussed collaboration opportunities with pharma, biotech, hospitals, and investors. The convention had more than 300 Participants coming from France, Europe and the USA to discuss collaborative opportunities in the field of oncology. The organizer, MATWIN (Maturation & Accelerating Translation With Industry) is the only French open-innovation platform specifically dedicated to oncology. MATWIN, a wholly owned subsidiary of Unicancer group (gathering all the French Comprehensive Cancer Centres) offers several actions (expertise, accelerating program, events, etc.) aiming at accelerating the development of innovative projects dedicated to the fight against cancer.

Taking a moment to highlight our CEO Dr. Wahid Awad, Ph.D. MBA participation at the second edition of the Deep Tech Summit DTS 2025, held this month at UM6P – University Mohammed VI Polytechnic in Benguerir, Morocco. This remarkable event brought together over 5,500 participants from 53 countries, to explore the transformative impact of AI on deep tech innovation across sectors like health, energy, agriculture, and governance. Our CEO contributed to the discussions on how precision medicine and AI are revolutionizing cancer care. Engaging with fellow innovators, researchers, and investors at DTS 2025 was both inspiring and energizing. The summit’s theme, “Redefining Progress: How Artificial Intelligence is Transforming Deep Tech Innovation”, resonated deeply with our mission to harness cutting-edge technology for meaningful healthcare advancements. A highlight of the summit was witnessing the recognition of the Egyptian VC Sawari Ventures (Ibrahim Ramadan) – and the participation of some of our partners from France such as Bpifrance (Inès TAZI) and Hello Tomorrow (Selma El Ouardi). We extend our heartfelt thanks to UM6P Ventures UM6P France STARTGATE and the whole organizing team for creating such a dynamic platform that fosters collaboration and innovation. Events like DTS 2025 are pivotal in positioning Africa as a global hub for deep tech excellence. We are excited to carry forward the insights and connections gained from this summit as we continue our journey at Rosetta Omics to transform cancer care through precision medicine and bridge Europe, Africa and North America in the process.

We are happy to announce that Our CEO, Wahid Awad was speaker at the AI Summit this June 2025, hosted by Aimfluance! 🚀. It was an honor to join such an incredible lineup of experts in the AI space, and I look forward to sharing insights on how AI is revolutionizing industries, particularly in healthcare.

Rosetta Omics attending the RAISE Summit 2025 in Paris. The RAISE Summit is a unique gathering of innovators, scientists, investors and policy leaders shaping the future of AI and deep tech. At Rosetta Omics, our work is focused on making omics data more actionable, helping bridge the gap between complex biology and real-world clinical impact paving the road to the implementation of precision medicine in cancer care. RAISE Summit brings together an inspiring mix of voices, founders, researchers, investors, and policymakers, all united by a shared mission: to build responsibly, push boundaries, and solve hard problems with AI.

Our CEO, Wahid Awad, Ph.D. MBA attending the Onco Startup Summit 2025, at the Cœur Défense Conference Center in Courbevoie. This event is part of the 8th edition of the French Oncology Interdisciplinary Days (Congrès IFODS) running from June 11–13. Jointly organized by Angels Santé Gustave Roussy Transfert Paris Saclay Cancer Cluster (PSCC) MATWIN OncoSTART and Réseau SATT. The summit brings together over 200 oncology innovation leaders—from entrepreneurs and startups to investors and public-private networks—working to accelerate breakthrough cancer solutions. At Rosetta Omics, we’re pushing the frontiers of precision medicine by enabling high-resolution tumor characterization. Our AI-driven insights support physicians in tailoring therapies, improving outcomes, and minimizing ineffective treatments.

Our CEO Dr. Wahid Awad, Ph.D. MBA taking part in one of the most vibrant innovation events in Europe, held at École Polytechnique on May 20–21! For the eighth edition, the Paris-Saclay ecosystem brings together an extraordinary network of scientists, entrepreneurs, investors, and R&D leader, all united to showcase cutting-edge research and game-changing technologies shaping the future. We are proud to represent our mission to revolutionize cancer care through multiomics and AI. This is where science meets business and where tomorrow’s breakthroughs are born.

Our CEO Dr. Wahid Awad, Ph.D. MBA Pitching Rosetta Omics at the Rising Starts ⭐️ in healthcare session during the Healthtech investment forum focusing on digital health, Medtech and devices.
The forum organized by Sachs Associates in Basel, Switzerland 🇨🇭

We had the privilege to join Servier’s very first Partnering Day at their R&D site in Saclay! This milestone event highlighted Servier’s progress in oncology, neurology, and digital transformation, while emphasizing the power of collaboration with external experts and biotech innovators. We were inspired by the shared vision: advancing therapeutic innovation together as One Innovation Engine. Servier’s 2030 partnership goals reaffirm their role as a committed partner of choice — always with patients at the center. At Rosetta Omics, we strongly believe that true breakthroughs in healthcare come from collaboration, knowledge exchange, and bold partnerships. 🚀 Events like this remind us that together, we can accelerate discoveries and bring transformative solutions to patients worldwide.

The Forum de la Santé Connectée (October 2022) was a flagship event by ACSEL’s Club Santé Connectée centered on the complex dynamics of digital health—its potential to build bridges as well as barriers. With a wide-ranging and expert panel, the forum emphasized themes like prevention, urban-rural care dynamics, human-centric innovation, and designing unified care pathways in a digital era.

Dr. Wahid Awad, CEO and Cofounder of Rosetta Omics will participate in the Johnson & Johnson Innovation – JLABS symposium on “Partnering and Business Models in Precision Medicine”. ”The symposium will investigate three topics in detail: Topic 1: Diagnostics & biomarkers During this session the speakers focused on innovations supporting the classification of patients into subpopulations based on differences in biological markers such as markers in blood samples, the nucleome or “omics”. Specific challenges such as the regulatory pathway and integration in standard-of-care will be addressed. Topic 2: Patient stratification using data sets. The discussion focused on the use of small or big data sets, such as those from biobanks to distinguish subgroups of patients. Solutions in this space might include longitudinal studies, federated learning in digital medical records, or imputation from one genotype to another. Issues to address might include governance of health-related data, infrastructure and system integration. Topic 3: Digital applications for Real-World Evidence studies

Pitching Rosetta Omics at VIVATech Paris 2024

Rosetta Omics , a deeptech (as qualified by Bpifrance) healthcare startup based in Paris and incubated at the prestigious Agoranov incubator – is at the forefront of precision medicine in oncology, leveraging AI and multiomics data to match cancer patients with the most effective treatments and to discover new biomarkers and therapeutic targets.

Had a great day at Paris-Saclay SPRING yesterday at HEC Paris! where i attended many intresting talks about deeptech.
It was wonderful opportunity to meet friends and current and future partners.
Special shoutout to Celine Triquel from Servier France Servier who spoke about their excellent approach with startups and their hashtagSpartners initiative with BioLabs BioLabs France.
Also, a big thank you to Hélène Sire, the site director of Bilabs Saclay, and the energetic Chaimaa Asri. I thoroughly enjoyed chatting with you all.
Many thanks to the Servier and Biolabs teams in France and the USA, including Johannes Fruehauf, Johanna Michielin, Anais Ralimbimanana.
Happy to have met you Nadia Benallal (La French Tech Grand Paris), Suzanne Tedeschi XAnge, Luísa Ferreira dos Santos Université Paris-Saclay La French Tech

A great #MEDICENDAY organized by Medicen Paris Region with a huge support from Région Ile de France. Congratulations to all the team for making it happen with such a class. “Proud to be part of this team as an executive board member and a long time supporter of Medicen Paris Region and it was also a great opportunity for our team Kevin Adam, PhD, MBE to meet many of our partners”. Paris Saclay Cancer Cluster (PSCC) Bpifrance Bpifrance Digital Venture Agoranov France Biotech La French Tech Agence de l’innovation en santé BioLabs France EIT Health France Choose Paris Region

Our CSO Dr. Kevin Adam, PhD, MBE attended the Rencontre Phases Précoces en Cancérologie (ancien compte – ne sera plus alimenté) on 30 November 2023. The 5th day of “Early Phases in Cancerology Meeting” took place at the Palais des Congrès in Issy-Les-Moulineaux, near Paris. The exchanges and debates for all the actors involved in this field of oncology had a common ambition “How can we make France the most attractive country for early phases of oncology?

Rosetta Omics team had the privilege of participating in the AMI Oncomatch event organized by Medicen Paris Region and Canceropôle Île-de-France held at Onepoint (Paris 16e).
I presented the vision behind Rosetta Omics and outlined our keen interest in fostering partnerships and collaborations.
Rosetta is actively seeking collaborations in the realms of multiomics, biopsies access, and artificial intelligence, aspiring to contribute to research consortiums at local, European, and global scales.
The Oncomatch call for expressions of interest serves as a catalyst, bringing together the entire oncology innovation ecosystem to nurture collaborative projects involving academic laboratories, clinics, startups, and industry partners. The goal is to streamline the formation of consortia and foster cross-disciplinary research projects capable of competing for partnership research project opportunities.
With more than 50 actors in oncology from Paris and allover France, in attendance, including Paris Saclay Cancer Cluster (PSCC) team, we engaged in fruitful discussions and exchanges on potential future projects.
It was truly gratifying to connect with both current and prospective partners, as well as many friends.
We look forward to continuing these discussions and collaborating to push the boundaries of innovation in cancer diagnosis and treatment.
With Kevin Adam, PhD, MBE

Excited to be part of the French Pavilion at the BIO International Convention 2024 in San Diego, California! 🌟
A very busy and successful conference with many B2B meetings with VCs, pharma companies and cancer clusters and hospitals.
Thank you to our sponsors and partners:
BioLabs BioLabs France Servier Servier France Medicen Paris Region Business France Business France North America France Biotech Choose Paris Region La French Tech Région Ile de France French Healthcare Association La French Tech San Diego Bpifrance Agoranov
Happy to have been able to present Rosetta Omics to Madame Julie Duhaut-Bedos ,the General counsel of France in Los Angeles, and Madame Lise ALTER, the Managing director of the Agence de l’innovation en santé

Rosetta Omics invited participant at the 34th edition of “La Nuit des Caducées” at the Pavillon Royal in Paris.
The event organized by Les Caducées ESCP (an Association of students of the Master’s in Pharmaceutical Management and Biotechnologies at ESCP Business School) (ESCP – MSc Biopharmaceutical Management) a specialized master led by my friend and Rosetta Omics Go-To-Market strategy International Consulting Project (ICP) supervisor for the coming 12 months, professors Frederic Jallat
This year’s theme, “Innovations et Technologies en Santé,” brought together over 300 healthcare professionals for an inspiring night of networking and celebration.
The student association is led this year by my friend Julien Ducloux-Baudinière organized a great event that was a great success and an opportunity for me to be there with my team Kevin Adam, PhD, MBE Noah Ibrahim Sultan, PhD

Happy to be back to my Dutch connections and to be hosted by the Embassy of the Kingdom of the Netherlands in France among many other Dutch entrepreneurs coming for Hello Tomorrow global summit or residing in Paris like me.

It was a great pleasure, to participate in Healthtech Trophies” by Francesca Gino 2024.
Despite the fact that Rosetta Omics did not participate in the 9 categories competition (maybe next year! 😉). I witnessed a great energy and gathering of talents from the Healthtech sector in France at the amazing Eiffel Tower Theatre in Paris for this 2024 edition hosted by the dynamic and talented Nicolas Rossignol!
France Biotech brings together over 450 entrepreneurs and innovative health companies. Their ambition is to showcase innovative health companies (hashtagBiotech, hashtagMedtech, Medical Diagnosis, Digital Health) at all stages of maturity.

Because the patient is at the center of Rosetta Omic’s strategy. Yesterday, our CEO Dr. Wahid Awad, Ph.D. MBA and our CSO Dr. Kevin Adam, PhD, MBE participated at the “Innovations au service des Parcours de Soins en ImmunoOncologi” forum.
The forum was organized by Bristol Myers Squibb in Paris and involved many roundtables and presentations around the new innovations serving the Care Pathways in ImmunoOncology.
The forum witnessed the participaton of many KOLs in the field of immunoencology in France, especially from Gustave Roussy Centre Léon Bérard Unicancer and many CHU from different parts of France.
Thank you Bristol Myers Squibb for the invitation and the organization.

Exciting day at the Hello Tomorrow Global Summit, particularly at the “Financing the Future” event! It’s been an inspiring experience connecting with innovative deeptech entrepreneurs and visionary investors who are actively shaping the future .
Special thanks to the supportive partners including Boston Consulting Group (BCG), Supernova Invest, and the IFC – International Finance Corporation.
Together, we’re driving impactful change and paving the way for a healthier, brighter future. Let’s keep pushing boundaries and accelerating progress!
Rosetta Omics : A deeptech startup in the oncology space is proud to be part of this collective effort by unlocking the road to precision medicine via multiomics and AI.

🎗️ Joining Hands for a Cause: French National Fight Cancer Week 🎗️

From March 18th to March 24th, France embraces solidarity and determination in the battle against cancer during the National Fight Cancer Week. This annual event stands as a beacon of hope, uniting communities, organizations, and individuals across the country in a shared mission to raise awareness, support those affected, and promote vital research.

During this week, initiatives ranging from fundraising events to educational campaigns flood the nation, amplifying the message of prevention, early detection, and support for patients and their families.
It’s a time to honor the resilience of survivors, remember those lost, and redouble efforts towards a future free from the grips of this disease.
Let’s paint France in hues of unity and compassion as we stand together, united in our commitment to fight cancer and strive for a healthier, brighter tomorrow. Together, we are stronger. Together, we can make a difference.

The Rosetta Omics team: our CEO, Dr. Wahid Awad, Ph.D. MBA and our CSO, Dr. Kevin Adam, PhD, MBE had the honor of presenting our inovative multiomics profiling solution (currently under development) for the multidisciplinary consultation meeting (Réunion de Concertation Pluridisciplinaire (RCP)), at the esteemed Gustave Roussy.
A heartfelt thank you to Dr. Mohamed Amine Bani, and Prof. Michel Ducreux for extending the invitation.
It was truly encouraging to witness the keen interest, curiosity, and receptiveness of the oncologists, pathologists, surgeons, and researchers we engaged with.
At Rosetta, we aspire to collaborate with hospitals and clinics across France, Europe, and the globe.
We aspire to empower caregivers with informed decision-making tools through our multiomics molecular profiling and AI solutions.
We eagerly anticipate the opportunity to collaborate with Gustave Roussy, leveraging innovation to enhance digestive cancer care and ultimately, improve patient outcomes.
It is important to mention that our CSO Dr. Kevin Adam, PhD, MBE did his master degree in oncology at Gustave Roussy

Our CEO Dr. Wahid Awad, Ph.D. MBA for the first time at the Apéro Innovation at Hotel Dieu Hospital
@Hôtel-Dieu is an initiative launched by the Greater Paris University Hospitals – AP-HP and Université Paris Cité to accelerate innovation in healthcare by enabling start-ups, researchers and caregivers from the 38 AP-HP hospitals to work together, in a different way, in one of the oldest hospitals in Europe, at the foot of Notre-Dame de Paris.
Nice presentation form Withings followed by a networking session at BioLabs France BioLabs facilities (with Christophe Tallec).
BioLabs France is a great place to meet likeminded entrepreneurs to build fruitful collaborations.

Our CEO Dr. Wahid Awad, Ph.D. MBA at Paris Saclay Cancer Cluster (PSCC) Thursday event (Jeudi PSCC 8) at the ACADEMIE NATIONALE DE MEDECINE where three intresting speakers from Orakl Oncology , Merck and Bioqube Ventures presented thier work around oncology translatinal models with focus on organoids.
Dr. Awad was also joined online by our CSO Dr. Kevin Adam, PhD, MBE
Rosetta Omics is looking forward to collaborating with all the actors in the oncology field as part of the Paris Saclay Cancer Cluster (PSCC) network

Our CSO Dr. Kevin Adam, PhD, MBE attended the Rencontre Phases Précoces en Cancérologie (ancien compte – ne sera plus alimenté) on 30 November 2023.
The 5th day of “Early Phases in Cancerology Meeting” took place at the Palais des Congrès in Issy-Les-Moulineaux, near Paris.
The exchanges and debates for all the actors involved in this field of oncology had a common ambition “How can we make France the most attractive country for early phases of oncology?
Rosetta Omics is striving to be part of this effort by building collaborations and partnerships with all the actors in the field.

To tackle complex issues, we need to have the ambition to build, finance and scale complex solutions.
The Hello Tomorrow Global Summit https://lnkd.in/eymRuQv is where it’s all happening.
The only event in the world, bringing together corporates, investors, startups, researchers, and institutions during
two days (9-10 March 2023) in Paris.
Our Founder & CEO Wahid Awad, Ph.D. at the summit to discuss collaboration and investing opportunities and learn about Rosetta Omics.

At the 9th edition of hashtagBIG2023 (Bpifrance inno generation).
The biggest deeptech conference organized by Bpifrance in Paris, France 🇫🇷
With ESCP Business School Blue Factory ESCP Rosetta Omics
I was alone last year representing Rosetta Omics and this year I am happy to be joined by Kevin Adam, PhD, MBE as our chief scientific officer.
Rosetta Omics will be back bigger and stronger next year, as a promising deep tech startup in the field of oncology precision medicine using the combination of multiomics profiling and machine learning/AI to help in the fight against cancer ♋️

EVENTS

phases précoces en cancérologie

Trinational HealthTech Days 2025 – Basel, Switzerland

Bio-Europe 2025, Vienna

11th – Société Française de Médecine Prédictive et Personnalisée Congress

Big 2025

AI4Immuno-Oncology

Rosetta Omics at BIO International Convention – Boston June 2025

GITEX AFRICA 2025, StartGate

Franco-Dutch Conference

AI for Health summit 2024

GITEX AFRICA

Viva Technology

Hello Tomorrow Global Summit

Medintechs 2023

3rd AI for Oncology congress in Milan, Italy

Abu Dhabi Global Health Week

JPM Week 2025

11th Annual Healthtech Investment Forum

Medintechs 2024

11th edition of JNDA – BRIDGE AFRICA

Boost event by CCI Paris IdF

Meet2win conference

2nd edition of the Deep Tech Summit DTS 2025

AI Summit by Aimfluance

RAISE Summit

Onco Startup Summit 2025

Paris-Saclay SPRING 2025

The Rising Starts

Servier first Partnering Day

Forum de la Santé Connectée

Johnson & Johnson symposium

VivaTech Paris 2024

Paris-Saclay SPRING at HEC Paris

Medintechs 2023

Phase Precoce Cancerologie

AMI Oncomatch event organized by Medicen Paris Region and Canceropôle Île-de-France

BIO International Convention

34th edition of “La Nuit des Caducées”

Embassy of the Kingdom of the Netherlands in France

Healthtech Trophies” by Francesca Gino 2024

Innovations au service des Parcours de Soins en ImmunoOncologi” forum

Hello Tomorrow Global Summit

🎗️ Joining Hands for a Cause: French National Fight Cancer Week 🎗️

Réunion de Concertation Pluridisciplinaire (RCP)

the Apéro Innovation at Hotel Dieu Hospital

Paris Saclay Cancer Cluster (PSCC)

Rencontre Phases Précoces en Cancérologie (ancien compte – ne sera plus alimenté)

The Hello Tomorrow Global Summit

9th edition of Bpifrance inno generation